Isatuximab in combination to treat relapsed/refractory MM

Venetoclax in patients with previously treated WM

Single cell profiling reveals key differences in architecture of stem and progenitor cells throughout life

ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy

Even late progressors with high risk factors in PRIMA prognostic index are more likely to die

Patient relevant outcomes and advocacy

The mutational landscape of AML

Development of a risk stratifying prognostic index for ALL

Specification of haematopoetic stem cell fate via modulation of mitochondrial activity

Onset and treatment of infantile leukaemia

Novel CD22 CAR-T therapy for paediatric leukaemia

Lymphoma guidelines in Venezuela